From the Academy of Managed Care Pharmacy 2012 Educational Conference: MS specialty drug treatment costs climb to two-thirds of total MS treatment cost

Multiple sclerosis (MS) specialty drug costs now account for more than two-thirds of MS patients' total cost of care, according to a new study presented at the Academy of Managed Care Pharmacy 2012 Educational Conference in Cincinnati, Ohio, in October.